Director, R&D Strategic Sourcing and Procurement

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Conshohocken, PA | 25/12/2025 01:12:59 AM | Salario: S/. $202000 - 246000 per year | Empresa: Madrigal

Director, Project Management

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Conshohocken, PA | 24/12/2025 19:12:05 PM | Salario: S/. $200000 - 244000 per year | Empresa: Madrigal

Medical Science Liaison-New York

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: New York City, NY | 06/01/2026 22:01:44 PM | Salario: S/. $195300 - 238700 per year | Empresa: Madrigal

Associate Director, Generative AI Engineer

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Conshohocken, PA | 25/11/2025 22:11:58 PM | Salario: S/. $191000 - 234000 per year | Empresa: Madrigal

Associate Director, Specialty and IDN Operations

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Massachusetts | 18/12/2025 03:12:37 AM | Salario: S/. $182000 - 222000 per year | Empresa: Madrigal

Associate Director, Global Health Economics and Outcomes Research

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Massachusetts | 22/11/2025 03:11:20 AM | Salario: S/. $179000 - 219000 per year | Empresa: Madrigal